title: Digoxigenin-end labeled oligonucleotides facilitate the detection of minimal residual disease in acute lymphoblastic leukemia.
authors.forename: M
authors.initials: M
authors.lastname: Nakao
authors.forename: J W
authors.initials: JW
authors.lastname: Janssen
authors.forename: M
authors.initials: M
authors.lastname: Schäfer
authors.forename: C R
authors.initials: CR
authors.lastname: Bartram
mesh_terms: D000328:Adult; D001345:Autoradiography; D004273:DNA, Neoplasm / Q000032:analysis*; D004076:Digoxigenin; D004797:Enzyme-Linked Immunosorbent Assay; D015328:Gene Rearrangement, B-Lymphocyte, Light Chain; D016694:Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; D005803:Genes, Immunoglobulin; D006801:Humans; D008163:Luminescent Measurements; D009363:Neoplasm Proteins / Q000235:genetics; D018365:Neoplasm, Residual; D009693:Nucleic Acid Hybridization; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000473:pathology*; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity
chemical_list: D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D011933:Reagent Kits, Diagnostic; D004076:Digoxigenin